r/pharmaindustry

I’m looking for some honest career advice from people in pharma/industry or anyone who has been in a similar situation.

I’m a PharmD + MBA and turning 39 this year. I worked as a retail Pharmacy Manager for 3 years before transitioning into pharma/industry because I knew retail wasn’t the long-term path I wanted.
My entry into industry was through a CRA role. I started at a CRO in a junior-level CRA position, then eventually moved to the sponsor side and was promoted to Sr. CRA. I’ve now been in clinical research for about 3.5 years total.

The issue is… I feel financially stuck.

I currently make ~$149k/year, which I know is objectively a solid salary, but living in a VHCOL area with a stay-at-home spouse, growing family, mortgage, and large student loans has made things extremely tight. We’re essentially paycheck to paycheck, and I feel like I’m falling behind financially despite working incredibly hard and trying to progress my career aggressively.

What’s been frustrating is how slow advancement can feel in pharma, especially starting from the CRA route. Promotions seem to take forever, particularly on the CRO side, which is one reason I moved to sponsor. I’m highly motivated to move into higher-level roles such as Clinical Development, Clinical Scientist/CSE/CDD, Medical Affairs, or Regulatory, but sometimes it feels like the timeline to get there is painfully long.

Meanwhile, I look around and see:
Commercial pilots becoming captains in a few years making $400k+
MDs in pharma significantly out-earning PharmDs
Anesthesiologists making $500–600k+
Other careers with much faster financial acceleration

And honestly, it’s discouraging.

Seeing careers like commercial pilots — where someone can make compensation comparable to doctorate-level healthcare professionals in a fraction of the time — really makes me question whether I entered the wrong industry altogether. Sometimes it feels like I invested so much time, education, sacrifice, and debt into becoming a PharmD + MBA, yet the financial return and upward mobility feel much slower than I expected.

Don’t get me wrong — I genuinely do love pharma and working in a clinical research setting. I enjoy collaborating cross-functionally on clinical studies, contributing scientifically, and being involved in drug development. There are many aspects of this industry that I truly enjoy and find meaningful. But lately I can’t help but wonder… is the grass greener on the other side?

I value quality of life, intellectual stimulation, and ideally a mostly remote/WFH career. I don’t want this post to come across as “money is all I care about,” because it’s not. But I also want financial security for my family, the ability to invest for the future, travel the world with my kids, and enjoy life a bit more without constant financial pressure.

For those further along in pharma:
Does it eventually get significantly better financially?
Is staying the course in pharma worth it?
Would pursuing a Clinical Development/CSE/CDD or Medical Affairs path materially change compensation/QOL?
Am I underestimating how difficult it would be to pivot into something completely different like becoming a pilot or going to medical school at this stage?
If you were in my shoes, would you double down in pharma or consider a major career pivot?

I’d really appreciate any honest advice or perspective from people who have been there.

Why does the AI conversation in pharma brand planning seem to be stuck in two camps:

1. Fear: hallucinations, regulatory risk, AI-generated content reaching HCPs/patients.
2. Hype: faster decks, cleaner slides, summarized research.

Both are mostly focused on the wrong applications in my opinion. I've seen the highest-value AI uses in brand planning:

• Synthesizing ATUs, ad tracking, advisory boards, field feedback, and competitive intel into usable planning inputs
• Collecting asynchronous stakeholder input from field, access, advocacy, etc. and surfacing consensus/tensions
• Simulating executive challenge sessions by generating the most likely leadership questions before the review

None of this is customer-facing. None requires enterprise AI platforms. It mostly requires good prompts, judgment, and a planning process worth accelerating.

AI can speed up synthesis and pressure-testing. But it can't fix weak strategy, false departmental alignment, or teams operating from different assumptions about the patient.

Curious whether others are seeing meaningful AI use in commercial planning — or mostly just deck polishing.

I wrote a longer version on the structural problems in pharma brand planning and the diagnostic questions 2027 plans should answer. Happy to share if useful.